Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies.

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne and Melbourne Health, Victoria, Australia.
Journal of affective disorders (Impact Factor: 3.76). 04/2011; 138(1-2):9-18. DOI: 10.1016/j.jad.2011.03.049
Source: PubMed

ABSTRACT Voxel-based morphometry (VBM) has been widely used to quantify structural brain changes associated with Major Depressive Disorder (MDD). While some consistent findings have been reported, individual studies have also varied with respect to the key brain regions affected by the illness, and how these abnormalities are related to patients' clinical characteristics. Here, we aimed to identify those brain regions that most consistently showed gray matter anomalies in MDD, and their clinical correlates, using meta-analytic techniques.
A systematic search of VBM studies was applied in MDD. Signed differential mapping, a new coordinate based neuroimaging meta-analysis technique, was applied to data collated from a total of 23 studies comparing regional gray matter volumes of 986 MDD patients and 937 healthy controls.
Gray matter was significantly reduced in a confined cluster located in the rostral anterior cingulate cortex (ACC). There were also gray matter reductions in dorsolateral and dorsomedial prefrontal cortex and decrease in the latter region was evident in patients with multiple-episodes. Amygdala and parahippocampal gray matter volumes were significantly reduced in studies including patients with comorbid anxiety disorders, as well as in first-episode/drug free samples.
Gray matter reduction in rostral ACC was the most consistent finding in VBM studies of MDD. The evidence for reductions in other regions within fronto-subcortical and limbic regions was less consistent. The associations between these gray matter anomalies and clinical characteristics, particularly measures relating to illness duration, suggest that chronic MDD has a robust and deleterious, albeit spatially focal, effect on brain structure.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Functional and anatomical deficits have been involved in the neurobiology of major depressive disorder (MDD). However, no study has ever been conducted to examine whether and how functional alterations are related to anatomical deficits in MDD. This study aimed to determine the association between brain functional and anatomical deficits in drug-naive MDD.
    Progress in Neuro-Psychopharmacology and Biological Psychiatry 05/2014; · 3.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The causal pathways leading to depression involve a combination of genetic and environmental risk factors and the relative contribution of these factors differ across patients. In addition, patients vary in the way they respond to treatment. The aim of this article is to discuss a candidate gene approach (5-HTTLPR) in the treatment of depression and how it may be implemented to individualize treatment plans for patients. First, we examine the role of 5-HTTLPR polymorphisms in biased emotion processing and in the interplay between emotion regulation and cognitive control. An intriguing finding is that the low expression short allele variant of 5-HTTLPR is best conceived as a gene that affects malleability or plasticity rather than specific vulnerability to depression. A shift from vulnerability to susceptibility has the potential to translate into new perspectives on individualized treatment of depression. The interplay between therapeutic intervention and genotype is a special case of gene-environment interactions (GxE). Within this new field, recently named "therapygenetics," a small number of studies have so far provided preliminary but provocative evidence of an association between the low expression 5-HTTLPT short allele and response to psychological treatment. Future research should expand into randomized controlled trial (RCT) designs to examine the likelihood of response to psychotherapy versus pharmacotherapy in the individual patient.
    Scandinavian Journal of Psychology 04/2014; · 1.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Depressive disorder I Emotions I Biological markers I Magnetic resonance imaging I Antidepressive agents I Cognitive behavioural treatment Opinion Statement Major depressive disorder (MDD) is associated with key regions of the brain involved in emotional processing. The present meta-analysis revealed widespread structural reduc-tions in limbic and prefrontal regions that occur in MDD, with no regions of increased grey matter volume. Functional impairments involve many of the same regions with dysregulated interactions between limbic and cortical structures. Longitudinal treat-ment studies have predominantly investigated pharmacological therapies, and there have been fewer studies of psychological treatments. Reports of increased hippocampal
    Current Treatment Options in Psychiatry. 07/2014; 1(3).


Available from
Jun 2, 2014